Your Guide to Financial Freedom
Google Accelerates in AI Chip Market—But Investors Await Gemini 4 Alphabet Inc. (GOOGL) is rapidly scaling its artificial intelligence (AI) accelerator chip business, becoming a notable player in the tech industry’s infrastructure arms race. A recent Morgan Stanley report highlights this growth but cautions investors that robust chip sales alone are unlikely to trigger a … Read more
Tesla Raises Cybertruck Prices Amid Sales Softness; TSLA Stock Approaches Key Level Tesla moved to increase the prices of its much-discussed Cybertruck on Tuesday, raising concerns and speculation across the auto and investment communities. The price hikes apply to two of the electric pickup’s trims as the company responds to declining sales since initial demand … Read more
The S&P 500 may still look resilient at the index level, but the underlying stock-by-stock picture is already much weaker. Even as many investors continue to wait for a broader market correction, the data show that a large share of the benchmark has already experienced one in its own right. Roughly 300 stocks in the … Read more
Rocket Lab USA (NASDAQ: RKLB) has staged a notable recovery after a brutal summer sell-off that erased more than half its value. The small-launch and space-systems company peaked near $151 in May before the SpaceX IPO triggered a sector-wide rotation that hammered space equities. With second-quarter earnings now digested and a steady drumbeat of defense-contract … Read more
Market Overview The Dow Jones Industrial Average finished higher even as broader market sentiment remained uneven, reflecting a session dominated by geopolitical headlines, tariff and trade concerns, and sharp sector rotation. Treasury Secretary Scott Bessent outlined new sanctions against Iran while President Donald Trump threatened Canada, adding another layer of uncertainty for investors already navigating … Read more
Guardant Health (GH) fell sharply on Monday after a court ruling turned a patent dispute into a major financial overhang. The company lost its case against privately held TwinStrand Biosciences and the University of Washington, and the judge ordered Guardant to pay more than $245.2 million in damages, accrued royalty and interest. In addition to … Read more
The biotechnology sector is experiencing a watershed moment following Moderna’s historic clinical trial success, creating a powerful tailwind for select industry leaders. On Wednesday, Moderna (NASDAQ: MRNA) shares skyrocketed 177% after its personalized mRNA cancer vaccine, developed in partnership with Merck (NYSE: MRK), became the first such therapy to succeed in a late-stage melanoma trial. … Read more
Tempus AI CFO James Rogers Cashes In $2.7M Worth of Shares—Here’s What It Means for Investors Tempus AI (NASDAQ: TEM) Chief Financial Officer James William Rogers sold 48,842 shares of Class A Common Stock on August 18 and August 19, 2026, according to a recent SEC Form 4 filing. The transactions, executed at a weighted-average … Read more
Palantir, Freeport-McMoRan, Micron Technology, Guardant Health, and EOG Resources are drawing investor attention as five stocks to watch near or above key buy points. The group spans artificial intelligence, commodities, semiconductors, health diagnostics, and energy, giving investors a broad view of where market leadership may be forming. According to the source article, Palantir and Micron … Read more
Market Overview: Nasdaq and S&P 500 Face First Weekly Drop in Four Weeks According to the latest market session, both the Nasdaq Composite and the S&P 500 recorded their first weekly decline in four weeks. Despite this pullback, each index maintained year‑to‑date gains above 12%. This performance indicates that the broader upward trend remains intact, … Read more